Skip to main content

Table 1 Correlation analysis between clinical characteristics and MATH values in the TCGA-BLCA project

From: Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis

Characteristics

Number of patients

Percent (%)

MATH ± SD

p value

Age, median (IQR)

408 (34–90)

  

p = 0.388

 ≤ 50

25

6.1

41.5 ± 19

 

 51–74

254

61.3

46.1 ± 16

 

 ≥ 75

133

32.6

46.5 ± 13

 

Gender

   

p = 0.527

 Male

304

73.8

46.2 ± 16

 

 Female

108

26.2

45.2 ± 13

 

Race

   

p = 0.484

 Asian

44

11.2

43.3 ± 19

 

 Caucasian

327

83.0

46.0 ± 14

 

 African

23

5.8

45.6 ± 16

 

 Unkown

18

Unkown

Unkown

 

Histologic subtype

   

p = 0.162

 Papillary

134

32.8

44.4 ± 18

 

 Non-papillary

274

67.2

46.7 ± 14

 

 Unkown

5

Unkown

Unkown

 

Stage

   

p = 0.425

 Stage I

2

0.5

49.5 ± 50

 

 Stage II

131

32.0

44.3 ± 16

 

 Stage III

141

34.4

45.6 ± 15

 

 Stage IV

136

33.2

47.4 ± 13

 

 Unkown

2

Unkown

Unkown

 

Grade

   

p = 0.024

 High-grade

388

94.9

46.2 ± 15

 

 Low-grade

21

5.1

38.6 ± 18

 

 Unkown

3

\

  

Recurrence

   

p = 0.389

 Recur

147

45.1

46.8 ± 15

 

 Free

179

54.9

45.3 ± 16

 

 Unkown

86

Unkown

Unkown

Â